Efficient Human Cell Coexpression System and Its Application to the Production of Multiple Coronavirus Antigens
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, C. | - |
dc.contributor.author | Jeong, Y.K. | - |
dc.contributor.author | Yu, J. | - |
dc.contributor.author | Shin, H.J. | - |
dc.contributor.author | Ku, K.B. | - |
dc.contributor.author | Cha, H.J. | - |
dc.contributor.author | Han, J.H. | - |
dc.contributor.author | Hong, S.-A. | - |
dc.contributor.author | Kim, B.-T. | - |
dc.contributor.author | Kim, S.-J. | - |
dc.contributor.author | Woo, J.-S. | - |
dc.contributor.author | Bae, S. | - |
dc.date.accessioned | 2021-12-03T02:41:48Z | - |
dc.date.available | 2021-12-03T02:41:48Z | - |
dc.date.created | 2021-08-31 | - |
dc.date.issued | 2021-04 | - |
dc.identifier.issn | 2701-0198 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/129021 | - |
dc.description.abstract | Coproduction of multiple proteins at high levels in a single human cell line would be extremely useful for basic research and medical applications. Here, a novel strategy for the stable expression of multiple proteins by integrating the genes into defined transcriptional hotspots in the human genome is presented. As a proof-of-concept, it is shown that EYFP is expressed at similar levels from hotspots and that the EYFP expression increases proportionally with the copy number. It is confirmed that three different fluorescent proteins, encoded by genes integrated at different loci, can be coexpressed at high levels. Further, a stable cell line is generated, producing antigens from different human coronaviruses: MERS-CoV and HCoV-OC43. Antibodies raised against these antigens, which contain human N-glycosylation, show neutralizing activities against both viruses, suggesting that the coexpression system provides a quick and predictable way to produce multiple coronavirus antigens, such as the recent 2019 novel human coronavirus. © 2021 The Authors. Advanced Biology published by Wiley-VCH GmbH | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | John Wiley and Sons Inc | - |
dc.title | Efficient Human Cell Coexpression System and Its Application to the Production of Multiple Coronavirus Antigens | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Woo, J.-S. | - |
dc.identifier.doi | 10.1002/adbi.202000154 | - |
dc.identifier.scopusid | 2-s2.0-85101017766 | - |
dc.identifier.wosid | 000672525100001 | - |
dc.identifier.bibliographicCitation | Advanced Biology, v.5, no.4 | - |
dc.relation.isPartOf | Advanced Biology | - |
dc.citation.title | Advanced Biology | - |
dc.citation.volume | 5 | - |
dc.citation.number | 4 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Materials Science | - |
dc.relation.journalWebOfScienceCategory | Materials Science, Biomaterials | - |
dc.subject.keywordPlus | RECEPTOR-BINDING DOMAIN | - |
dc.subject.keywordPlus | SUBUNIT VACCINE | - |
dc.subject.keywordPlus | GUIDE RNA | - |
dc.subject.keywordPlus | PROTEIN | - |
dc.subject.keywordPlus | TARGET | - |
dc.subject.keywordPlus | CAS9 | - |
dc.subject.keywordPlus | DNA | - |
dc.subject.keywordPlus | INTEGRATION | - |
dc.subject.keywordPlus | DESIGN | - |
dc.subject.keywordPlus | SITE | - |
dc.subject.keywordAuthor | coronaviruses | - |
dc.subject.keywordAuthor | CRISPR-Cas9 | - |
dc.subject.keywordAuthor | protein expression | - |
dc.subject.keywordAuthor | targeted knock-in | - |
dc.subject.keywordAuthor | vaccines | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.